Lexaria Bioscience Corp.
LEXX
$0.60
$0.034.44%
NASDAQ
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.56% | -47.45% | -105.37% | -134.87% | -72.50% |
| Total Depreciation and Amortization | 22.55% | -8.34% | 6.43% | -32.37% | -46.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.09% | 76.80% | 83.59% | 13.87% | 84.08% |
| Change in Net Operating Assets | -189.06% | 1,085.58% | 83.66% | 188.64% | 394.09% |
| Cash from Operations | -27.00% | -33.91% | -110.73% | -106.85% | -41.71% |
| Capital Expenditure | 39.64% | 100.00% | 42.79% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -117.95% | -77.02% | -50.00% | 53.52% | 54.92% |
| Cash from Investing | -50.22% | -12.82% | -28.84% | 17.45% | 20.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -12.69% | -59.70% | -41.39% | -41.39% | 34.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -12.69% | -59.70% | -41.39% | -40.69% | 36.99% |
| Foreign Exchange rate Adjustments | 164.34% | -94.51% | -156.85% | -171.56% | -373.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -176.03% | -162.00% | -191.26% | -173.03% | 23.04% |